Education
About Us
Working with TipRanks
Follow Us
Moonlake Immunotherapeutics (MLTX)
:MLTX
RESEARCH TOOLSreports
MLTX Analyst Ratings
Strong Buy
13 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
MLTX Stock 12 Month Forecast
Average Price Target
$76.00
▲(62.12%Upside)
| Highest Price Target$100.00 | Average Price Target$76.00 | Lowest Price Target$61.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Guggenheim
$80
Buy
70.65%
Upside
Reiterated
06/03/25
RBC Capital
$67
Buy
42.92%
Upside
Reiterated
06/03/25
Citi
$72
Buy
53.58%
Upside
Reiterated
06/02/25
H.C. Wainwright
$100
Buy
113.31%
Upside
Reiterated
05/27/25
Wolfe Research
$61
Buy
30.12%
Upside
Upgraded
05/19/25
Leerink Partners
$73
Buy
55.72%
Upside
Reiterated
05/13/25
LifeSci Capital
$75
Buy
59.98%
Upside
Reiterated
05/13/25
Needham
$66
Buy
40.78%
Upside
Reiterated
05/13/25
Wedbush
$78→$80
Buy
70.65%
Upside
Reiterated
05/13/25
TD Cowen
―
Buy
―
Reiterated
05/12/25
BTIG
$81→$85
Buy
81.31%
Upside
Reiterated
04/30/25
Stifel Nicolaus
$77
Buy
64.25%
Upside
Reiterated
04/10/25
Cantor Fitzgerald
―
Buy
―
Reiterated
04/04/25
Goldman Sachs
$82→$73
Buy
55.72%
Upside
Reiterated
02/27/25
Oppenheimer
$104
Buy
121.84%
Upside
Reiterated
12/11/24
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Guggenheim
$80
Buy
70.65%
Upside
Reiterated
06/03/25
RBC Capital
$67
Buy
42.92%
Upside
Reiterated
06/03/25
Citi
$72
Buy
53.58%
Upside
Reiterated
06/02/25
H.C. Wainwright
$100
Buy
113.31%
Upside
Reiterated
05/27/25
Wolfe Research
$61
Buy
30.12%
Upside
Upgraded
05/19/25
Leerink Partners
$73
Buy
55.72%
Upside
Reiterated
05/13/25
LifeSci Capital
$75
Buy
59.98%
Upside
Reiterated
05/13/25
Needham
$66
Buy
40.78%
Upside
Reiterated
05/13/25
Wedbush
$78→$80
Buy
70.65%
Upside
Reiterated
05/13/25
TD Cowen
―
Buy
―
Reiterated
05/12/25
BTIG
$81→$85
Buy
81.31%
Upside
Reiterated
04/30/25
Stifel Nicolaus
$77
Buy
64.25%
Upside
Reiterated
04/10/25
Cantor Fitzgerald
―
Buy
―
Reiterated
04/04/25
Goldman Sachs
$82→$73
Buy
55.72%
Upside
Reiterated
02/27/25
Oppenheimer
$104
Buy
121.84%
Upside
Reiterated
12/11/24
Best Analysts Covering MoonLake Immunotherapeutics
1 Month
xxx
Success Rate
12/22 ratings generated profit
Average Return
+12.33%
reiterated a xxx
rating 27 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 54.55% of your transactions generating a profit, with an average return of +12.33% per trade.
3 Months
xxx
Success Rate
15/22 ratings generated profit
Average Return
+36.13%
reiterated a xxx
rating 27 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 68.18% of your transactions generating a profit, with an average return of +36.13% per trade.
1 Year
Success Rate
14/22 ratings generated profit
Average Return
+91.74%
reiterated a buy rating 27 days ago
Copying Thomas Smith's trades and holding each position for 1 Year would result in 63.64% of your transactions generating a profit, with an average return of +91.74% per trade.
2 Years
xxx
Success Rate
15/22 ratings generated profit
Average Return
+90.60%
reiterated a xxx
rating 27 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 68.18% of your transactions generating a profit, with an average return of +90.60% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
MLTX Analyst Recommendation Trends
Rating
Feb 25
Mar 25
Apr 25
May 25
Jun 25
Strong Buy
11
14
17
18
16
Buy
6
4
5
4
4
Hold
1
1
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
18
19
22
22
20
Each month's total comprises the sum of three months' worth of ratings.
MLTX Financial Forecast
MLTX Stock Forecast FAQ
What is MLTX’s average 12-month price target, according to analysts?
Based on analyst ratings, Moonlake Immunotherapeutics’s 12-month average price target is 76.00.
What is MLTX’s upside potential, based on the analysts’ average price target?
Moonlake Immunotherapeutics has 62.12% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is MLTX a Buy, Sell or Hold?
Moonlake Immunotherapeutics has a consensus rating of Strong Buy which is based on 13 buy ratings, 0 hold ratings and 0 sell ratings.
What is Moonlake Immunotherapeutics’s price target?
The average price target for Moonlake Immunotherapeutics is 76.00. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $100.00 ,the lowest forecast is $61.00. The average price target represents 62.12% Increase from the current price of $46.88.
The highest analyst price target is $100.00 ,the lowest forecast is $61.00. The average price target represents 62.12% Increase from the current price of $46.88.
What do analysts say about Moonlake Immunotherapeutics?
Moonlake Immunotherapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 13 Wall Streets Analysts.
How can I buy shares of MLTX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.